Literature DB >> 22993073

Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula.

Mykola V Tsapenko, Livius V d'Uscio, Joseph P Grande, Anthony J Croatt, Melissa C Hernandez, Allan W Ackerman, Zvonimir S Katusic, Karl A Nath.   

Abstract

Vascular access dysfunction causes morbidity in hemodialysis patients. This study examined the generation and pathobiological significance of superoxide anion in a rat femoral arteriovenous fistula (AVF). One week after AVF creation, there was increased production of superoxide anion accompanied by decreased total superoxide dismutase (SOD) and Cu/Zn SOD activities and induction of the redox-sensitive gene heme oxygenase-1. Immunohistochemical studies of nitrotyrosine formation demonstrated that peroxynitrite, a product of superoxide anion and nitric oxide, was present in increased amounts in endothelial and smooth muscle cells in the AVF. Because uncoupled NOS isoforms generate superoxide anion, and NOS coupling requires tetrahydrobiopterin (BH(4)) as a cofactor, we assessed NOS uncoupling by determining the ratio of BH(4) to dihydrobiopterin (BH(2)); the BH(4)-to-BH(2) ratio was markedly attenuated in the AVF. Because Src is a vasculopathic signaling species upstream and downstream of superoxide anion, such expression was evaluated; expression of Src and phosphorylated Src was both markedly increased in the AVF. Expression of NADPH oxidase (NOX) 1, NOX2, NOX4, cyclooxygenase (COX) 1, COX2, p47(phox), and p67(phox) was all unchanged, as assessed by Western analyses, thereby suggesting that these proteins may not be involved in increased production of superoxide anion. Finally, administration of tempol, a superoxide anion scavenger, decreased neointima formation in the juxta-anastomotic venous segment and improved AVF blood flow. We conclude that the AVF exhibits increased superoxide anion generation that may reflect the combined effects of decreased scavenging by SOD and increased generation by uncoupled NOS, and that enhanced superoxide anion production promotes juxta-anastomotic stenosis and impairs AVF function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993073      PMCID: PMC3532470          DOI: 10.1152/ajprenal.00449.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  36 in total

1.  Outcomes of arteriovenous fistula creation after the Fistula First Initiative.

Authors:  Carrie A Schinstock; Robert C Albright; Amy W Williams; John J Dillon; Eric J Bergstralh; Bernice M Jenson; James T McCarthy; Karl A Nath
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

2.  Mechanisms of increased vascular superoxide production in human varicose veins.

Authors:  Bartłomiej Guzik; Maciej Chwała; Paweł Matusik; Dominik Ludew; Dominik Skiba; Grzegorz Wilk; Wojciech Mrowiecki; Bogdan Batko; Andrzej Cencora; Bogusław Kapelak; Jerzy Sadowski; Ryszard Korbut; Tomasz J Guzik
Journal:  Pol Arch Med Wewn       Date:  2011-09

3.  Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice.

Authors:  Livius V d'Uscio; Leslie A Smith; Zvonimir S Katusic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

4.  MCP-1 contributes to arteriovenous fistula failure.

Authors:  Julio P Juncos; Joseph P Grande; Lu Kang; Allan W Ackerman; Anthony J Croatt; Zvonimir S Katusic; Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

5.  ß-Catenin is markedly induced in a murine model of an arteriovenous fistula: the effect of metalloproteinase inhibition.

Authors:  Karl A Nath; Joseph P Grande; Lu Kang; Julio P Juncos; Allan W Ackerman; Anthony J Croatt; Zvonimir S Katusic
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-29

Review 6.  Redox regulation of protein kinases as a modulator of vascular function.

Authors:  Greg A Knock; Jeremy P T Ward
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

Review 7.  Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Authors:  Tohru Fukai; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

8.  Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse.

Authors:  J P Juncos; M J Tracz; A J Croatt; J P Grande; A W Ackerman; Z S Katusic; K A Nath
Journal:  Kidney Int       Date:  2008-03-26       Impact factor: 10.612

Review 9.  Current management of vascular access.

Authors:  Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2007-05-30       Impact factor: 8.237

10.  CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis.

Authors:  Ziad A Ali; Christina A Bursill; Gillian Douglas; Eileen McNeill; Marianna Papaspyridonos; Amy L Tatham; Jennifer K Bendall; Asim M Akhtar; Nicholas J Alp; David R Greaves; Keith M Channon
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more
  18 in total

1.  Objectives and design of the hemodialysis fistula maturation study.

Authors:  Laura M Dember; Peter B Imrey; Gerald J Beck; Alfred K Cheung; Jonathan Himmelfarb; Thomas S Huber; John W Kusek; Prabir Roy-Chaudhury; Miguel A Vazquez; Charles E Alpers; Michelle L Robbin; Joseph A Vita; Tom Greene; Jennifer J Gassman; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2013-08-28       Impact factor: 8.860

Review 2.  Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Authors:  Timmy Lee
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

3.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

4.  Superoxide in AVF dysfunction: a new target for intervention.

Authors:  Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

Review 5.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

6.  Chinese herbal medicine formula tao hong si wu decoction protects against cerebral ischemia-reperfusion injury via PI3K/Akt and the Nrf2 signaling pathway.

Authors:  Li Li; Na Yang; Ling Nin; Zhilong Zhao; Lu Chen; Jie Yu; Zhuyun Jiang; Zhendong Zhong; Daiwen Zeng; Hongyi Qi; Xiaoyu Xu
Journal:  J Nat Med       Date:  2014-08-23       Impact factor: 2.343

7.  Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD.

Authors:  Yun Wang; Anlin Liang; Jinlong Luo; Ming Liang; Guofeng Han; William E Mitch; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

Review 8.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 9.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

10.  Functioning of an arteriovenous fistula requires heme oxygenase-2.

Authors:  Lu Kang; Joseph P Grande; Gianrico Farrugia; Anthony J Croatt; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.